Vivodyne named #1 “Small but Mighty” Company
Launched in 2021, Vivodyne’s platform allows fully automated, complex studies at a far larger scale and lower cost than would be possible with manual experimentation.
COVID Vaccines and Boosters Provoke Robust Immune Response
Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness
Newly discovered ‘encrypted peptides’ with antibiotic properties
A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties. Global public health officials are concerned about the r
Inspiring people, place, and purpose
Gutmann spearheaded the creation of an innovation ecosystem for Penn, Philadelphia, and beyond by transforming technology transfer at Penn to be both more faculty- and industry-friendly.
Medical device startup Neuralert has big 2022 plans
The device's algorithm maps out asymmetric arm movements or weakness, a tell-tale sign of a stroke, CEO Eric Corkhill said. Here's why he's so excited about its potential.
Decade-long remission after CAR T cell therapy
Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.
It’s official: Philly Tech Week is back and IRL in 2022
The 12th annual celebration of technology, entrepreneurship and innovation will be held May 6 to 14, 2022 with a mix of in-person and virtual events.
Two Penn spinouts on the Technical.ly Philly RealLIST standout tech companies
Of the 20 companies on the Technical.ly Philly RealLIST, two are Penn spinout companies: Lumify and Neuralert.
Penn’s Gene Therapy Program signs manufacturing partnership with the Center for Breakthrough Medicines
The Center for Breakthrough Medicines and Penn’s Gene Therapy Program (GTP) entered into a multi-year collaboration focusing on the manufacturing and testing of modern gene therapy processes.
The Center for Breakthrough Medicines and Penn partner in the manufacturing of gene therapies
Penn’s Innovation in Process Science combines with CBM manufacturing capability to develop large-scale gene therapy manufacturing capacity, testing, and analytics